Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Jefferson scientists find tumor suppressor gene protects against pre-cancerous development

03.11.2006
Cell biologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have provided further evidence that a gene thought to play a role in suppressing tumors actually can protect against the development of pre-cancerous cell growth as well.

The researchers say that the gene, caveolin-1 (Cav-1), which they found in two major types of breast cells, could be a potential target for future drugs aimed at preventing breast cancer. The work also suggests a potentially important role of the tumor "microenvironment" in the cancerous process.

Cav-1 is involved in breast cancer onset and progression, and it's present in epithelial cells and mammary "fat pads," or stromal cells. The researchers, led by Michael Lisanti, M.D., Ph.D., professor of cancer biology at Jefferson Medical College of Thomas Jefferson University and Jefferson's Kimmel Cancer Center, showed striking effects in mice that lacked Cav-1, particularly in stromal cells.

Reporting November 1, 2006 in the American Journal of Pathology, Dr. Lisanti, Kimmel Cancer Center director Richard Pestell, M.D., Ph.D., professor and chair of cancer biology at Jefferson Medical College, and their co-workers showed in a series of experiments that tumor cells grew larger in mammary fat pads lacking Cav-1, and that metastatic breast cancer cells transplanted to fat pads with Cav-1 failed to grow.

"There could also be human conditions where loss of Cav-1 in the stroma could be predisposing patients toward increased risk," Dr. Lisanti says. "This provides the hard genetic evidence of a cause-effect relationship between loss of Cav-1 in the stroma and tumor growth. This could be predictive by looking at Cav-1 in the stroma and seeing if this is a bad risk factor."

The researchers found that mice lacking the Cav-1 gene showed a cell thickening in the breast duct and hyperplasia – or excessive cell growth – in the lobulo-alveolar area. Both are locations where breast cancer can begin.

In one study, they took a tumor from a mouse and put it in a stromal fat pad in both a normal mouse and in a mouse lacking Cav-1 and discovered that the tumor grew twice as large in the latter. "The stroma clearly has effects on normal mammary growth, hyperplasia and tumorigenesis," Dr. Lisanti says.

Dr. Lisanti and his team performed another experiment in which they compared the effects of implanting metastatic breast cancer cells in mice with Cav-1 and those lacking the gene. When they implanted such cells in the mouse flank, which is not a location at which tumors grow, nothing happened. But when they put the cells in the mammary fat pad, tumors formed. When they implanted metastatic breast cancer cells with Cav-1 in the fat pads, "it had a huge effect," Dr. Lisanti says, blocking tumor growth.

"This tumor suppressor effect of Cav-1 depends on the location of the cells," he explains. "This means it is specific to the mammary fat pad. The mammary stromal and epithelial cells somehow sense the microenvironment and respond to the Cav-1 gene."

The researchers believe that the effect also depends on the activity of the cyclin D1 gene, a cancer-causing gene overexpressed in about half of all breast cancers. Using a mouse model of premalignant growth in mice carrying the cyclin D1 gene but lacking Cav-1 – which worsens the condition – the researchers added Cav-1 and found "it completely represses the phenotype, meaning it can not only suppress the tumor, but also the premalignant state caused by cyclinD1 upregulation."

Turning down cyclinD1 activity relies on the cellular microenvironment, Dr. Lisanti says. "We think Cav-1 can block the transforming effects of cyclinD1," he says. "It could be a very important therapeutic candidate for developing caveolin mimetic drugs suppressing cyclinD1 activity."

Dr. Lisanti believes that Cav-1 "could be important for early intervention because patients with epithelial cell hyperplasia could be given Cav-1 mimetic drugs to see if they could suppress this."

Steve Benowitz | EurekAlert!
Further information:
http://www.jefferson.edu

Further reports about: Cav-1 HDL-cholesterol Lisanti breast cyclinD1 mammary stroma stromal

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>